In the HOMA − IR ≤ 1 group, the subjects with nonobese NAFLD also had higher BMI (23.6 ± 1.0 vs. 22.1 ± 1.8 kg/m2, P < 0.001) (Figure 2(a)), higher ALT (24.9 ± 8.8 vs. 19.6 ± 8.4 U/L, P = 0.021) (Figure 2(b)), higher AST (21.6 ± 5.2 vs. 19.1 ± 4.6 U/L, P = 0.002) (Figure 2(c)), higher TG (1.6 ± 0.8 vs. 1.1 ± 0.7 mmol/L, P < 0.001) (Figure 2(d)), and higher HbA1c (5.6 ± 0.2 vs. 5.4 ± 0.3%, P < 0.001) (Figure 2(e)) values relative to patients without NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.